Bacteriophage Treatment for Serious Infections Is Back!
JAMA Clinical Reviews14 Marras 2017

Bacteriophage Treatment for Serious Infections Is Back!

Bacteriophages are viruses that infect and kill bacteria. When they were first discovered in the early part of the 20th century, there was great enthusiasm for their potential use to treat all sorts of bacterial infections. They were supplanted by antibiotics and although they remained critically important in research that led to the understanding of DNA and how it works, bacteriophages never really made it in the therapeutic world. Now that multiple-drug-resistant bacteria are becoming increasingly common, there is renewed interest in using bacteriophages to treat bacterial infection.

Links:

YouTube video summarizing the career and science of Félix d'Hérelle-one of the discoverers of bacteriophages

Dr. Felix d'Herelle Canadian Medical Hall of Fame Laureate 2007

Detailed history of the development of bacteriophage research in Georgia

A Stalinist Antibiotic Alternative from New York Times Magazine, February 6, 2000

Reprint of Twort's initial description of a substance killing bacteria discovered while trying to grow viruses. Although Twort did not identify bacteriophages in his experiment, he believed there was some toxic entity that killed bacteria present in his experiments.

An investigation on the nature of ultra-microscopic viruses1 by Twort FW, L.R.C.P. Lond., M.R.C.S.

Reprint and translation of d'Herelle's original 1917 description of bacteriophages isolated from soldiers recovering from dysentery.

On an invisible microbe antagonistic to dysentery bacilli. Note by M. F. d'Herelle, presented by M. Roux. Comptes Rendus Academie des Sciences 1917; 165:373–5

Review of the non-English-language literature on bacteriophage therapy of infection

Bacteriophage Therapy Antimicrob Agents Chemother. 2001 Mar; 45(3): 649–659.

Review of the history bacteriophage research and its effect on scientific development and clinical medicine

The Murky Origin of Snow White and Her T-Even Dwarfs Genetics 155: 481–486 (June 2000)

News report from UC San Diego on treatment of the patient described in the podcast

Novel Phage Therapy Saves Patient with Multidrug-Resistant Bacterial Infection

2017 JAMA Medical News article on the use of bacteriophage to treat a patient with multidrug-resistant Acinetobacter infection

Phage Therapy's Role in Combating Antibiotic-Resistant Pathogens

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(491)

Alcohol-Related Liver Disease

Alcohol-Related Liver Disease

Alcohol-related liver disease is the leading cause of liver-related morbidity and mortality and the most common indication for liver transplant in Europe and the US. Author Aleksander Krag, MD, PhD, o...

6 Heinä 20min

An Overview of Familial Hypercholesterolemia

An Overview of Familial Hypercholesterolemia

Worldwide, heterozygous familial hypercholesterolemia (FH) affects approximately 1 in 250 to 350 individuals. Author James Stein, MD, of the University of Wisconsin School of Medicine and Public Healt...

29 Kesä 10min

Transforming Communication Between Patients and Clinicians

Transforming Communication Between Patients and Clinicians

Patient portal messaging continues to expand across health systems, and it has become an increasingly important method for patient-clinician communication. Authors Michal Mankowski, PhD, assistant pro...

22 Kesä 15min

Low Back Pain: Diagnosis and Treatment

Low Back Pain: Diagnosis and Treatment

Nonspecific low back pain is a leading cause of disability, with most cases lacking a clear anatomic cause. This episode reviews  risk factors, diagnosis, and current  evidence-based treatments for ac...

15 Kesä 26min

Survivors of Cyanotic Congenital Heart Disease

Survivors of Cyanotic Congenital Heart Disease

Cyanotic congenital heart diseases occur in approximately 0.2% of live births in the US, but survival to adulthood is common with current surgical interventions. JAMA Associate Editor David Simel, MD,...

8 Kesä 23min

Point-of-Care Ultrasound for the Diagnosis of Pneumonia: A Review

Point-of-Care Ultrasound for the Diagnosis of Pneumonia: A Review

Community-acquired pneumonia (CAP) accounts for 1.4 million emergency department visits and 740 000 hospitalizations annually in the US. Author Andre Kumar, MD, MEd, of Stanford University School of M...

3 Kesä 16min

Cesarean Delivery on Request

Cesarean Delivery on Request

Cesarean delivery on maternal request requires individualized counseling. Reduced risks of pelvic floor disorders should be weighed against surgical risks and future risks including abnormal placentat...

27 Touko 15min

Diet and Exercise Recommendations for Patients Taking GLP-1 Receptor Agonists

Diet and Exercise Recommendations for Patients Taking GLP-1 Receptor Agonists

The GLP-1 receptor agonists reduce appetite and greatly facilitate weight loss. Robert Kushner, MD, of Northwestern University Feinberg School of Medicine joins JAMA Deputy Editor Mary M. McDermott, M...

20 Touko 14min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
utelias-mieli
filocast-filosofian-perusteet
tiedekulma-podcast
docemilia
rss-ammamafia
hippokrateen-vastaanotolla
rss-tiedetta-vai-tarinaa
rss-vaasan-yliopiston-podcastit
rss-duodecim-lehti